Diaceutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

AIM:DXRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
29 Jul 24	BuyUK£149	Jordan Clark	Individual	113	UK£1.32
29 Jul 24	BuyUK£147	Susanne Munksted	Individual	111	UK£1.32
29 Jul 24	BuyUK£149	Nicholas Roberts	Individual	113	UK£1.32
29 Jul 24	BuyUK£149	Julie Browne	Individual	113	UK£1.32
22 May 24	BuyUK£51,471	Graham Paterson	Individual	39,934	UK£1.29
26 Apr 24	BuyUK£149	Jordan Clark	Individual	145	UK£1.03
26 Apr 24	BuyUK£149	Nicholas Roberts	Individual	145	UK£1.03
06 Mar 24	BuyUK£33,061	Graham Paterson	Individual	33,564	UK£0.99

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DXRX?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	32,970	0.039%
Public Companies	98,004	0.116%
State or Government	877,192	1.04%
General Public	5,171,775	6.12%
VC/PE Firms	11,873,500	14.1%
Individual Insiders	19,876,647	23.5%
Institutions	46,544,784	55.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 86.87% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.7%	Peter Keeling	15,752,049	UK£19.8m	0%	no data
14.1%	Gresham House Asset Management Limited	11,873,500	UK£14.9m	9.7%	1.04%
9.5%	Canaccord Genuity Asset Management Limited	8,021,681	UK£10.1m	1.58%	0.49%
4.75%	Universal-Investment-Luxembourg SA	4,009,764	UK£5.0m	0%	0.14%
3.54%	Ryan Keeling	2,990,643	UK£3.8m	0%	no data
3.21%	BlackRock, Inc.	2,714,165	UK£3.4m	40.9%	no data
3.01%	West Elk Capital, LLC	2,543,281	UK£3.2m	0%	17.77%
2.77%	Octopus Investments Limited	2,339,000	UK£2.9m	1.54%	0.18%
2.5%	Herald Investment Management Ltd.	2,111,000	UK£2.6m	0%	0.18%
2.43%	Amati Global Investors Ltd.	2,049,000	UK£2.6m	0%	0.57%
2.2%	Danske Capital Denmark	1,859,547	UK£2.3m	-30.8%	0.01%
1.9%	Orange River Management LP	1,605,000	UK£2.0m	-35.1%	6.34%
1.82%	Danske Invest Management A/S	1,534,320	UK£1.9m	-15%	1.13%
1.8%	Handelsbanken Asset Management	1,517,000	UK£1.9m	-18.9%	no data
1.79%	Joh. Berenberg, Gossler & Co. KG, Asset Management Arm	1,513,382	UK£1.9m	-29.4%	0.09%
1.69%	EdenTree Investment Management Limited	1,430,500	UK£1.8m	1.78%	0.13%
1.69%	Edentree Asset Management Limited	1,430,500	UK£1.8m	0%	0.37%
1.65%	BNY Mellon Advisors, Inc.	1,395,000	UK£1.8m	-3.46%	0.01%
1.51%	Columbia Management Investment Advisers, LLC	1,276,929	UK£1.6m	23.2%	no data
1.27%	Jefferies Group LLC, Asset Management Arm	1,074,262	UK£1.3m	6,610%	0.17%
1.18%	River Global Investors LLP	1,000,000	UK£1.3m	-33.3%	0.08%
1.05%	Danske Invest Rahastoyhtio Oy	885,153	UK£1.1m	-13.5%	2.04%
1.04%	Invest Northern Ireland	877,192	UK£1.1m	0%	no data
0.99%	Castlefield Investments	840,375	UK£1.1m	-16%	0.17%
0.87%	London Wealth Management Limited	737,604	UK£925.7k	0%	0.05%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 19:01
End of Day Share Price	2024/12/24 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Diaceutics PLC is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Hayley Palmer	Canaccord Genuity
Colin Smith	Capital Access Group
Oliver Juggins	Capital Access Group